Research and Markets: Autism-Pipeline Insights Analysis 2015

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2hkd29/autismpipeline) has announced the addition of the "Autism-Pipeline Insights" subscription to their offering.

This Autism-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Autism.

This report provides information on the therapeutic development based on the Autism dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Key Topics Covered:

1. Autism Overview
2. Autism Pipeline Therapeutics
3. Autism Therapeutics under Development by Companies
4. Autism Late Stage Products (Filed and Phase III)
5. Comparative Analysis
6. Autism Mid Clinical Stage Products (Phase II)
7. Comparative Analysis
8. Autism Early Clinical Stage Products (Phase I and IND Filed)
9. Comparative Analysis
10. Autism Discovery and Pre-Clinical Stage Products
11. Comparative Analysis
12. Drug Candidate Profiles
13. Autism - Therapeutics Assessment
14. Assessment by Monotherapy Products
15. Assessment by Combination Products
16. Assessment by Route of Administration
17. Assessment by Molecule Type
18. Autism - Discontinued Products
19. Autism - Dormant Products
20. Companies Involved in Therapeutics Development for Autism
21. Appendix

For more information visit http://www.researchandmarkets.com/research/2hkd29/autismpipeline